Kratom bill gets tweaked after hours of testimony
The Idaho Senate Health and Welfare Committee has heard testimony on a bill to regulate kratom in the state, with some advocating for its use as a pain relief alternative and others warning of its potential for addiction and overdose. The bill would limit kratom sales to adults 21 and older and restrict sales to natural leaf products, while also establishing labeling requirements and liability protections for retailers.
The Idaho Senate Health and Welfare Committee heard testimony on a bill to regulate kratom. The bill would limit sales to adults 21 and older and restrict sales to natural leaf products. It would also ban the sale of unsafe or synthetic products. The bill aims to establish labeling requirements and provide liability protections for retailers. Kratom is a supplement that acts on the same receptors as opioids and is sold for pain relief and other purposes. The committee heard mixed testimony, with some advocating for its use and others warning of its risks.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.